HIV Vaccine Trials Announced
December 2011 has been a big month for HIV and AIDS awareness and prevention. December 1st was World AIDS Day, a day encouraging people to not only be aware of HIV and AIDS but to also act aware. And to end December on a positive note, phase 1 trials for a new AIDS vaccine have been announced.
Researchers from the University of Western Ontario, led by virologist Dr. Chil-Yong Kang, have been working on a vaccine that could prevent HIV infection by exposing the body to a non-pathogenic or ‘inactive’ form of the virus. The inactive virus would not be harmful but would rather allow the body to create antibodies for the virus to protect against potential future exposure. In this sense, the HIV vaccine would work like other vaccines, such as the seasonal flu shot.
Trials are expected to start in the new year and if results are promising, the vaccine could be on the market within the next 5 years.
To read more about this story, see the media release.